Contact | Print version | PDF version | Send article | RSS feed

Ablynx Appoints Medical Director and Business Development Director

26 May 2009 - Ablynx announced that it has appointed Dr. Christian Duby as Medical Director and Mr. Sean A. MacDonald as Business Development Director.
 
Dr. Duby has over sixteen years of experience in the pharmaceutical and medical industry, with expertise in the fields of allergy, cardiology and pneumology. In his position as Medical Director, Dr. Duby will be closely involved in the development and management of Ablynx’s therapeutic programmes. He will report to Josi Holz, Chief Medical Officer. Christian Duby holds a Master of Science degree in Bioengineering from Columbia University and a Medical Doctor’s degree from the Free University of Brussels. He started his career in industry 1992 at UCB Pharma and has also held senior clinical research and marketing positions within pharmaceutical companies including Amgen, GSK and Servier.
 
Mr. MacDonald joins the Ablynx business development team from TopoTarget A/S in Denmark where he was the Director of Business Development. He will report to Eva-Lotta Allan, Chief Business Officer. Sean A. MacDonald has an extensive background in venture capital, commercial development, and deal-making in the biotechnology industry internationally. He studied at the University of Ottawa in Canada and holds a BSc in biology and biotechnology and an MBA. He founded MD Biotech in 1998, a biotechnology consultancy. After marketing roles at Shire Pharmaceuticals, Mr. MacDonald joined the investment team at SGF Health Inc. Prior to joining TopoTarget, he held business development positions at H3 Pharma and Bioneer A/S.